African efforts to produce Covid-19 vaccines on the continent may face a setback amid a dearth of orders for the injections.
The continent’s biggest drugmaker is making the doses on behalf of Johnson & Johnson at a plant in South Africa and in March said it agreed to make those shots under its own brand. The Durban-based company ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.